Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berit J Brinkmann

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
STAR Protocols|November 8, 2021
Processing human lymph node samples for single-cell assaysTobias Roider, Berit J Brinkmann, Sascha Dietrich
Blood Advances|September 29, 2021
An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodiesTobias Roider, Berit J Brinkmann, Vladislav Kim, et al.
Blood|May 28, 2024
CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo modelsBerit J Brinkmann, Alessia Floerchinger, Christina Schniederjohann, et al.
Nature Cell Biology|February 21, 2024
Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entitiesTobias Roider, Marc A Baertsch, Donnacha Fitzgerald, et al.
Nature Communications|October 20, 2022
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A Herbst, Mattias Vesterlund, Alexander J Helmboldt, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
STAR Protocols|November 8, 2021
Processing human lymph node samples for single-cell assaysTobias Roider, Berit J Brinkmann, Sascha Dietrich
Blood Advances|September 29, 2021
An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodiesTobias Roider, Berit J Brinkmann, Vladislav Kim, et al.
Blood|May 28, 2024
CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo modelsBerit J Brinkmann, Alessia Floerchinger, Christina Schniederjohann, et al.
Nature Cell Biology|February 21, 2024
Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entitiesTobias Roider, Marc A Baertsch, Donnacha Fitzgerald, et al.
Nature Communications|October 20, 2022
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A Herbst, Mattias Vesterlund, Alexander J Helmboldt, et al.
Pageof 1